Tag

Pharmaceutical Research & Development

1 article

SPARC Q1 FY27 Net Loss ₹20.98 Crore

SPARC reported a standalone net loss of ₹20.98 crore for Q1 FY27, a decline from a profit of ₹1,760.70 crore in the previous quarter. The quarter's performance was impacted by the absence of the prior